Building Biotech from Regensburg: Why Location Still Matters in Deep Tech
Digital tools have globalized research, but biotech remains place-based: laboratories, specialist talent, universities, clinics and regional networks still matter.
Deep tech is global in knowledge flow, but local in execution. Biotech companies need access to scientific talent, laboratory infrastructure, specialized service providers, clinical and academic networks, and trusted partners who understand the constraints of molecular innovation.
Regensburg offers a relevant regional environment for life-science activity. BioPark Regensburg connects biotechnology, medical technology, pharmaceutical and academic actors in a compact ecosystem. For early-stage biotech work, this proximity can reduce coordination friction and improve access to conversations that matter.
For ProtoVela, being located at BioPark Regensburg is therefore not only an address. It is a credibility signal: the company is embedded in a life-science context rather than operating as a generic digital consultancy detached from the realities of biotech development.